These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10375031)

  • 1. Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies.
    Shepherd PS; Da Costa CR; Cridland JC; Gilmore KS; Johnstone AP
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):197-206. PubMed ID: 10375031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.
    Nicholson LB; Vlase H; Graves P; Nilsson M; Molne J; Huang GC; Morgenthaler NG; Davies TF; McGregor AM; Banga JP
    J Mol Endocrinol; 1996 Apr; 16(2):159-70. PubMed ID: 9156519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folding of the recombinant human thyrotropin (TSH) receptor extracellular domain: identification of folded monomeric and tetrameric complexes that bind TSH receptor autoantibodies.
    Graves PN; Vlase H; Davies TF
    Endocrinology; 1995 Feb; 136(2):521-7. PubMed ID: 7530646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
    Haraguchi K; Saito T; Endo T; Onaya T
    Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide sequences from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin (TSH) receptor are similar to TSH and inhibit TSH-increased cAMP production in FRTL-5 thyroid cells.
    Taub R; Hsu JC; Garsky VM; Hill BL; Erlanger BF; Kohn LD
    J Biol Chem; 1992 Mar; 267(9):5977-84. PubMed ID: 1313425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor.
    Davies TF; Bobovnikova Y; Weiss M; Vlase H; Moran T; Graves PN
    Thyroid; 1998 Aug; 8(8):693-701. PubMed ID: 9737366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autoantibodies to the thyrotropin receptor: recognition of linear, folded, and glycosylated recombinant extracellular domain.
    Vlase H; Graves PN; Magnusson RP; Davies TF
    J Clin Endocrinol Metab; 1995 Jan; 80(1):46-53. PubMed ID: 7829638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding.
    Seetharamaiah GS; Wagle NM; Morris JC; Prabhakar BS
    Endocrinology; 1995 Jul; 136(7):2817-24. PubMed ID: 7540542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.
    Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G
    J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies.
    Oda Y; Sanders J; Evans M; Kiddie A; Munkley A; James C; Richards T; Wills J; Furmaniak J; Smith BR
    Thyroid; 2000 Dec; 10(12):1051-9. PubMed ID: 11201849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization and internalization of a thyrotrophin receptor lacking the cytoplasmic carboxy-terminal region.
    Haraguchi K; Saito T; Kaneshige M; Endo T; Onaya T
    J Mol Endocrinol; 1994 Dec; 13(3):283-8. PubMed ID: 7893346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading.
    Vlase H; Nakashima M; Graves PN; Tomer Y; Morris JC; Davies TF
    Endocrinology; 1995 Oct; 136(10):4415-23. PubMed ID: 7664661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of soluble, disulfide bond-stabilized, prokaryotically expressed human thyrotropin receptor ectodomain.
    Bobovnikova Y; Graves PN; Vlase H; Davies TF
    Endocrinology; 1997 Feb; 138(2):588-93. PubMed ID: 9002990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional site on the human TSH receptor: a potential therapeutic target in Graves' disease.
    Johnstone AP; Cridland JC; Da Costa CR; Nussey SS; Shepherd PS
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):437-41. PubMed ID: 14510905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse monoclonal antibody to the TSHR.
    Stankowiak-Kulpa H; Sanders J; Depraetere H; Jeffreys J; Evans M; Richards T; Furmaniak J; Smith BR
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):345-51. PubMed ID: 16088319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.